Literature DB >> 27143554

Increased ADAMTS1 mediates SPARC-dependent collagen deposition in the aging myocardium.

Hiroe Toba1, Lisandra E de Castro Brás2, Catalin F Baicu3, Michael R Zile4, Merry L Lindsey5, Amy D Bradshaw4.   

Abstract

Secreted protein acidic and rich in cysteine (SPARC) is a collagen-binding matricellular protein highly expressed during fibrosis. Fibrosis is a prominent component of cardiac aging that reduces myocardial elasticity. Previously, we reported that SPARC deletion attenuated myocardial stiffness and collagen deposition in aged mice. To investigate the mechanisms by which SPARC promotes age-related cardiac fibrosis, we evaluated six groups of mice (n = 5-6/group): young (3-5 mo old), middle-aged (10-12 mo old), and old (18-29 mo old) C57BL/6 wild type (WT) and SPARC-null (Null) mice. Collagen content, determined by picrosirius red staining, increased in an age-dependent manner in WT but not in Null mice. A disintegrin and metalloproteinase with thrombospondin-like motifs 1 (ADAMTS1) increased in middle-aged and old WT compared with young, whereas in Null mice only old animals showed increased ADAMTS1 expression. Versican, a substrate of ADAMTS1, decreased with age only in WT. To assess the mechanisms of SPARC-induced collagen deposition, we stimulated cardiac fibroblasts with SPARC. SPARC treatment increased secretion of collagen I and ADAMTS1 (both the 110-kDa latent and 87-kDa active forms) into the conditioned media as well as the cellular expression of transforming growth factor-β1-induced protein (Tgfbi) and phosphorylated Smad2. An ADAMTS1 blocking antibody suppressed the SPARC-induced collagen I secretion, indicating that SPARC promoted collagen production directly through ADAMTS1 interaction. In conclusion, ADAMTS1 is an important mediator of SPARC-regulated cardiac aging.

Entities:  

Keywords:  a disintegrin and metalloproteinase with thrombospondin-like motifs 1; fibroblast; heart; matrix metalloproteinase; secreted protein acidic and rich in cysteine

Mesh:

Substances:

Year:  2016        PMID: 27143554      PMCID: PMC4935141          DOI: 10.1152/ajpendo.00040.2016

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  48 in total

1.  Versican V1 proteolysis in human aorta in vivo occurs at the Glu441-Ala442 bond, a site that is cleaved by recombinant ADAMTS-1 and ADAMTS-4.

Authors:  J D Sandy; J Westling; R D Kenagy; M L Iruela-Arispe; C Verscharen; J C Rodriguez-Mazaneque; D R Zimmermann; J M Lemire; J W Fischer; T N Wight; A W Clowes
Journal:  J Biol Chem       Date:  2001-01-26       Impact factor: 5.157

2.  SPARC inhibits epithelial cell proliferation in part through stimulation of the transforming growth factor-beta-signaling system.

Authors:  Barbara J Schiemann; Jason R Neil; William P Schiemann
Journal:  Mol Biol Cell       Date:  2003-06-27       Impact factor: 4.138

Review 3.  Temporal and spatial expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases following myocardial infarction.

Authors:  Merry L Lindsey; Rogelio Zamilpa
Journal:  Cardiovasc Ther       Date:  2010-07-14       Impact factor: 3.023

4.  Upregulation of VCAM-1 and ICAM-1 at atherosclerosis-prone sites on the endothelium in the ApoE-deficient mouse.

Authors:  Y Nakashima; E W Raines; A S Plump; J L Breslow; R Ross
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

5.  Protease profiling of liver fibrosis reveals the ADAM metallopeptidase with thrombospondin type 1 motif, 1 as a central activator of transforming growth factor beta.

Authors:  Katia Bourd-Boittin; Dominique Bonnier; Anthony Leyme; Bernard Mari; Pierre Tuffery; Michel Samson; Frédéric Ezan; Georges Baffet; Nathalie Theret
Journal:  Hepatology       Date:  2011-12       Impact factor: 17.425

Review 6.  TGF-beta signalling from cell membrane to nucleus through SMAD proteins.

Authors:  C H Heldin; K Miyazono; P ten Dijke
Journal:  Nature       Date:  1997-12-04       Impact factor: 49.962

7.  Age-dependent alterations in fibrillar collagen content and myocardial diastolic function: role of SPARC in post-synthetic procollagen processing.

Authors:  Amy D Bradshaw; Catalin F Baicu; Tyler J Rentz; An O Van Laer; D Dirk Bonnema; Michael R Zile
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-11       Impact factor: 4.733

8.  Human abdominal aortic aneurysm is characterized by decreased versican concentration and specific downregulation of versican isoform V(0).

Authors:  A D Theocharis; I Tsolakis; A Hjerpe; N K Karamanos
Journal:  Atherosclerosis       Date:  2001-02-01       Impact factor: 5.162

9.  Forced expression of MMP9 rescues the loss of angiogenesis and abrogates metastasis of pancreatic tumors triggered by the absence of host SPARC.

Authors:  Shanna Arnold; Emilia Mira; Sabeeha Muneer; Grzegorz Korpanty; Adam W Beck; Shane E Holloway; Santos Mañes; Rolf A Brekken
Journal:  Exp Biol Med (Maywood)       Date:  2008-04-29

Review 10.  Collagen network of the myocardium: function, structural remodeling and regulatory mechanisms.

Authors:  K T Weber; Y Sun; S C Tyagi; J P Cleutjens
Journal:  J Mol Cell Cardiol       Date:  1994-03       Impact factor: 5.000

View more
  21 in total

Review 1.  Matrix metalloproteinase-12 as an endogenous resolution promoting factor following myocardial infarction.

Authors:  Alan J Mouton; Osvaldo J Rivera Gonzalez; Amanda R Kaminski; Edwin T Moore; Merry L Lindsey
Journal:  Pharmacol Res       Date:  2018-10-28       Impact factor: 7.658

2.  Dissecting the role of myeloid and mesenchymal fibroblasts in age-dependent cardiac fibrosis.

Authors:  JoAnn Trial; Celia Pena Heredia; George E Taffet; Mark L Entman; Katarzyna A Cieslik
Journal:  Basic Res Cardiol       Date:  2017-05-06       Impact factor: 17.165

3.  Temporal dynamics of cardiac hypertrophic growth in response to pressure overload.

Authors:  Yuan Wang; Yuannyu Zhang; Guanqiao Ding; Herman I May; Jian Xu; Thomas G Gillette; Hang Wang; Zhao V Wang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2017-08-19       Impact factor: 4.733

Review 4.  Proteomic analysis of the cardiac extracellular matrix: clinical research applications.

Authors:  Merry L Lindsey; Mira Jung; Michael E Hall; Kristine Y DeLeon-Pennell
Journal:  Expert Rev Proteomics       Date:  2018-01-09       Impact factor: 3.940

5.  Transgenic overexpression of macrophage matrix metalloproteinase-9 exacerbates age-related cardiac hypertrophy, vessel rarefaction, inflammation, and fibrosis.

Authors:  Hiroe Toba; Presley L Cannon; Andriy Yabluchanskiy; Rugmani Padmanabhan Iyer; Jeanine D'Armiento; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-12-23       Impact factor: 4.733

Review 6.  The impact of aging on cardiac extracellular matrix.

Authors:  Cesar A Meschiari; Osasere Kelvin Ero; Haihui Pan; Toren Finkel; Merry L Lindsey
Journal:  Geroscience       Date:  2017-01-17       Impact factor: 7.713

Review 7.  A Disintegrin and Metalloproteinase (ADAM) and ADAM with thrombospondin motifs (ADAMTS) family in vascular biology and disease.

Authors:  Sheng Zhong; Raouf A Khalil
Journal:  Biochem Pharmacol       Date:  2019-03-21       Impact factor: 5.858

8.  Identification of coordinately regulated microRNA-gene networks that differ in baboons discordant for LDL-cholesterol.

Authors:  Genesio M Karere; Jeremy P Glenn; Shifra Birnbaum; Roy Garcia; John L VandeBerg; Laura A Cox
Journal:  PLoS One       Date:  2019-03-15       Impact factor: 3.240

Review 9.  Extracellular matrix roles in cardiorenal fibrosis: Potential therapeutic targets for CVD and CKD in the elderly.

Authors:  Hiroe Toba; Merry L Lindsey
Journal:  Pharmacol Ther       Date:  2018-08-25       Impact factor: 12.310

10.  The Mouse Heart Attack Research Tool 1.0 database.

Authors:  Kristine Y DeLeon-Pennell; Rugmani Padmanabhan Iyer; Yonggang Ma; Andriy Yabluchanskiy; Rogelio Zamilpa; Ying Ann Chiao; Presley L Cannon; Abdullah Kaplan; Courtney A Cates; Elizabeth R Flynn; Ganesh V Halade; Lisandra E de Castro Brás; Merry L Lindsey
Journal:  Am J Physiol Heart Circ Physiol       Date:  2018-05-18       Impact factor: 4.733

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.